The Drug-Induced Cardiotoxicity Website and App
Frequency - Incidence
Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Cement embolism
Publications
Acute pulmonary embolism following N-butyl-cyanoacrylate endoscopic injection sclerotherapy.
Annals of gastroenterology. 2012;25(3):261
Education and imaging: gastrointestinal: pulmonary embolism of cyanoacrylate glue following endoscopic injection of gastric varices.
Journal of gastroenterology and hepatology. 2012;27(12):1874
[Pulmonary embolism by cyanoacrylate following embolisation of an arteriovenous malformation].
Revue des maladies respiratoires. 2009;26(1):74-7
Cyanoacrylate in the treatment of gastric varices complicated by multiple pulmonary emboli.
Internal medicine journal. 2006;36(7):462-5
Fatal N-butyl-2-cyanoacrylate pulmonary embolism after sclerotherapy for variceal bleeding.
Endoscopy. 2005;37(7):687
Pulmonary embolization of 2-octyl cyanoacrylate after endoscopic injection therapy for gastric variceal bleeding.
Mayo Clinic proceedings. 2004;79(11):1455-8
N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding.
Journal of computer assisted tomography. 2001;25(1):16-22